Advertisement

Clinical Oral Investigations

, Volume 18, Issue 8, pp 1919–1923 | Cite as

Oxidative stress and recurrent aphthous stomatitis

  • Jose BaganEmail author
  • Guillermo Saez
  • Carmen Tormos
  • Carmen Gavalda
  • Jose M. Sanchis
  • Leticia Bagan
  • Crispian Scully
Original Article

Abstract

Objectives

This study analyzed the oxidative stress status in patients with recurrent aphthous stomatitis (RAS) in the presence and absence of active ulceration.

Material and methods

Oxidative stress was analyzed in peripheral mononuclear cells of 28 RAS patients with active ulceration and 29 controls. A further blood sample was collected from nine subjects randomly selected from the 28 RAS cases, during the period in which the patients did not have active oral ulceration. The reduced glutathione (GSH), malondialdehyde (MDA), and oxidized glutathione (GSSG) levels were measured in these samples.

Results

The mean MDA and GSSG levels were significantly higher in patients with active RAS than in the controls, while GSH was lower in the RAS group (p < 0.01). There was a nonsignificant tendency toward higher MDA and GSSG levels in patients with major RAS compared with minor RAS. On comparing the serum findings in the nine RAS patients in the presence and absence of lesions, the presence of ulceration was associated with even higher MDA and GSSG levels and lower GSH concentrations (p < 0.05)

Conclusions

Oxidative stress was detected in our RAS patients.

Keywords

Recurrent aphthous stomatitis Oxidative stress Malondialdehyde (MDA) Reduced glutathione (GSH) Oxidized glutathione (GSSG) 

Notes

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. 1.
    Scully C, Porter S (2008) Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 46:198–206PubMedCrossRefGoogle Scholar
  2. 2.
    Jurge S, Kuffer R, Scully C, Porter SR (2006) Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis 12:1–21PubMedCrossRefGoogle Scholar
  3. 3.
    Natah SS, Hayrinen-Immonen R, Hietanen J (2000) Increased density of lymphocytes bearing gamma/delta T-cell receptors in recurrent aphthous ulceration (RAU). Int J Oral Maxillofac Surg 29:375–380PubMedCrossRefGoogle Scholar
  4. 4.
    Savage NW, Seymour GJ, Kruger BJ (1986) Expression of class I and class II major histocompatibility complex antigens on epithelial cells in recurrent aphthous stomatitis. J Oral Pathol 15:191–195PubMedCrossRefGoogle Scholar
  5. 5.
    Sun A, Chu CT, Liu BY et al (2000) Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers. Proc Natl Sci Counc Repub China B 24:116–122PubMedGoogle Scholar
  6. 6.
    Pekiner FN, Aytugar E, Demirel GY et al (2012) Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations. J Oral Pathol Med 41:73–79PubMedCrossRefGoogle Scholar
  7. 7.
    Bachtiar EW, Cornain S, Siregar B et al (1998) Decreased CD4+/CD8+ ratio in major type of recurrent aphthous ulcers: comparing major to minor types of ulcers. Asian Pac J Allergy Immunol 16:75–79PubMedGoogle Scholar
  8. 8.
    Sistig S, Vucicevic-Boras V, Lukac J et al (2002) Salivary IgA and IgG subclasses in oral mucosal diseases. Oral Dis 8:282–286PubMedCrossRefGoogle Scholar
  9. 9.
    Baccaglini L, Lalla RV, Bruce AJ, Sartori-Valinotti JC, Latortue MC, Carrozzo M, Rogers RS 3rd (2011) Urban legends: recurrent aphthous stomatitis. Oral Dis 17:755–770PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Brocklehurst P, Tickle M, Glenny AM et al (2012) Systemic interventions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database Syst Rev. 12;9:CD00541111.Google Scholar
  11. 11.
    Cimen MY, Kaya TI, Eskandari G et al (2003) Oxidant/antioxidant status in patients with recurrent aphthous stomatitis. Clin Exp Dermatol 28:647–650PubMedCrossRefGoogle Scholar
  12. 12.
    Karincaoglu Y, Batcioglu K, Erdem T et al (2005) The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J Oral Pathol Med 34:7–12PubMedCrossRefGoogle Scholar
  13. 13.
    Yardim-Akaydin S, Sepici A, Ozkan Y et al (2006) Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease. Scand J Rheumatol 35:61–64PubMedCrossRefGoogle Scholar
  14. 14.
    Cağlayan F, Miloglu O, Altun O et al (2008) Oxidative stress and myeloperoxidase levels in saliva of patients with recurrent aphthous stomatitis. Oral Dis 14:700–704PubMedCrossRefGoogle Scholar
  15. 15.
    Arikan S, Durusoy C, Akalin N et al (2009) Oxidant/antioxidant status in recurrent aphthous stomatitis. Oral Dis 15:512–515PubMedCrossRefGoogle Scholar
  16. 16.
    Momen-Beitollahi J, Mansourian A, Momen-Heravi F et al (2010) Assessment of salivary and serum antioxidant status in patients with recurrent aphthous stomatitis. Med Oral Patol Oral Cir Bucal 15:e557–e561PubMedCrossRefGoogle Scholar
  17. 17.
    Navarro J, Obrador E, Pellicer JA et al (1997) Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med 22:1203–1209PubMedCrossRefGoogle Scholar
  18. 18.
    Brigelius R, Muckel C, Akerboom TP et al (1983) Identification and quantitation of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. Biochem Pharmacol 32:2529–2534PubMedCrossRefGoogle Scholar
  19. 19.
    Wong SH, Knight JA, Hopfer SM et al (1987) Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33:214–220PubMedGoogle Scholar
  20. 20.
    Collado R, Oliver I, Tormos C et al (2012) Early ROS-mediated DNA damage and oxidative stress biomarkers in monoclonal B lymphocytosis. Cancer Lett 317:144–149PubMedCrossRefGoogle Scholar
  21. 21.
    Mansego ML, Redon J, Martinez-Hervas S et al (2011) Different impacts of cardiovascular risk factors on oxidative stress. Int J Mol Sci 12:6146–6163PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Castañer O, Fitó M, López-Sabater MC et al (2011) The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clin Nutr 30:490–493PubMedCrossRefGoogle Scholar
  23. 23.
    Klaunig JE, Kamendulis LM (2004) The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 44:239–267PubMedCrossRefGoogle Scholar
  24. 24.
    Moore T, Le A, Niemi AK (2013) A new LC-MS/MS method for the clinical determination of reduced and oxidized glutathione from whole blood. J Chromatogr B Anal Technol Biomed Life Sci 929:51–55CrossRefGoogle Scholar
  25. 25.
    Redón J, Oliva MR, Tormos C et al (2003) Antioxidant activities and oxidative stress by products in human hypertension. Hypertension 41:1096–1101PubMedCrossRefGoogle Scholar
  26. 26.
    Chaves FJ, Corella D, Blesa S et al (2007) Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels. Pharmacogenet Genomics 17:589–596PubMedCrossRefGoogle Scholar
  27. 27.
    López-Uriarte P, Nogués R, Saez G et al (2010) Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin Nutr 29:373–380PubMedCrossRefGoogle Scholar
  28. 28.
    Mitjavila MT, Fandos M, Salas-Salvadó J et al (2012) The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled, trial. Clin Nutr(Aug 31)Google Scholar
  29. 29.
    Oliva MR, Ripoll F, Muñiz P et al (1997) Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog 18:232–243PubMedCrossRefGoogle Scholar
  30. 30.
    Sanchez M, Torres JV, Tormos C et al (2006) Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2′-deoxyguanosine in advanced epithelial ovarian carcinoma of a Spanish community. Cancer Lett 233:28–35PubMedCrossRefGoogle Scholar
  31. 31.
    Oltra AM, Carbonell F, Tormos C et al (2001) Antioxidant enzyme activities and the production of MDA and 8-oxo-dG in chronic lymphocytic leukemia. Free Radic Biol Med 30:1286–1292PubMedCrossRefGoogle Scholar
  32. 32.
    Kryston TB, Georgiev AB, Pissis P et al (2011) Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res 711:193–201PubMedCrossRefGoogle Scholar
  33. 33.
    Baggiolini M, Wymann MP (1990) Turning on the respiratory burst. Trends Biochem Sci 15:69–72PubMedCrossRefGoogle Scholar
  34. 34.
    Gloire G, Piette J (2009) Redox regulation of nuclear post-translational modifications during NF-kappaB activation. Antioxid Redox Signal 11:2209–2222PubMedCrossRefGoogle Scholar
  35. 35.
    Rahman I, Biswas SK, Kirkham PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439–1452PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Jose Bagan
    • 1
    Email author
  • Guillermo Saez
    • 2
  • Carmen Tormos
    • 2
  • Carmen Gavalda
    • 1
  • Jose M. Sanchis
    • 1
  • Leticia Bagan
    • 1
  • Crispian Scully
    • 3
  1. 1.Oral Medicine Department, Service of Stomatology and Maxillofacial Surgery, University General HospitalUniversity of ValenciaValenciaSpain
  2. 2.Department of Biochemistry, School of MedicineUniversity of ValenciaValenciaSpain
  3. 3.University College LondonLondonUK

Personalised recommendations